SHARE THIS VIDEO —
CDC panel recommends lifting pause on J&J vaccine after rare blood clots
An advisory committee to the CDC recommended that the Johnson & Johnson Covid-19 vaccine resume distribution after rare blood clots were reported.
we and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences. by using the site, you consent to these cookies. for more information on cookies including how to manage your consent visit our cookie policy.